Developer docs
API playgroundTry for free, no card

Search company profiles

Project Mine

Full company profile

uuid0025t5m

Namestring
Project Mine
Legal namestring
Project MinE
Websiteurl
projectmine.com
Company typeenum
Private
Founded yearint
2013
Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersUtrecht, Netherlands
HQ citystring
Utrecht
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ALS genetics research, whole genome sequencing, genomic data consortium, rare disease genomics, neurodegenerative disease research
Industry2 codes
PRIMARYHLAJAIAK
Public Health Genomics & Sequencing (WGS/Metagenomics) Networks
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks
SECONDARYHLAJABAC
Laboratory-Based Surveillance & Genomic Epidemiology (WGS/NGS)
Healthcare & Life Sciences/Public Health, Government & Regulators/Disease Surveillance, Epidemiology & Outbreak Response
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715
  • Other Computer Related Services541519
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Genomic Research Consortium
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Research Funding and Grants
TypeData Monetisation
Description

Project MinE is a non-profit research consortium funded by the Dutch ALS Foundation and other research grants. All data used in publications was made accessible through funding by the Dutch ALS Foundation.

projectmine.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Infrastructure, Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Project MinE is an international research consortium of 30+ centers across 21 countries that collects, processes, and shares whole genome sequencing (WGS) data from ALS patients and healthy controls. It operates a controlled-access Data Access Program, a public Variant Browser, and downloadable GWAS summary statistics, supported by six specialized working groups covering phenotyping, association testing, epigenetics, structural variation, non-coding variation, and trans-ancestral genetics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 25% of ALS patients now have identifiable genetic cause (up from 20%)
+2 more records
Product overview1 text field

Project MinE is the largest ALS genetics research consortium in the world, comprising over 30 research centers from 21 countries. The consortium operates as a unified research platform centered on a whole genome sequencing (WGS) database of ALS patients and healthy controls. The core offerings include the Project MinE Data Browser for variant visualization, downloadable GWAS summary statistics from landmark publications, a controlled WGS data access program for qualified researchers, and specialized working group services providing standardized methodologies for phenotyping, association testing, epigenetics, structural variation, non-coding variation, and trans-ancestral genetics research. The consortium has produced major publications in Nature Genetics (2016, 2021) and contributed harmonized data to the Longitude Prize on ALS initiative.

Product and service4 records
1Project MinE Data Browser
CategoryData visualization / genomics browser
Description

Web-based variant browser enabling visualization and exploration of whole genomes from European-ancestry populations, ALS GWAS summary statistics, and burden test results across over 15,000 genes; aimed at qualified researchers studying ALS genetics.

2ALS GWAS Summary Statistics
CategoryGenomic data product
Description

Downloadable GWAS summary statistics from cross-ancestry and European-ancestry meta-analyses, rare-variant burden analysis results, and eQTL SMR summary statistics for eQTLGen and MetaBrain datasets; intended for use by qualified ALS genetics researchers.

3WGS Data Access Program
CategoryData access service
Description

Controlled data access service that allows qualified researchers to request individual-level genotype or whole genome sequencing data via a formal application process, data access agreements, and secure data transfer mechanisms; available to both academic and commercial researchers, with commercial access limited.

4Working Group Research Services
CategoryCollaborative research services
Description

Six specialized working groups (Phenotyping, Analysis and Association Testing, Epigenetics, Genomic Structural Variation, Non-coding Genomic Variation, and Trans-Ancestral Genetics) providing standardized methodologies, SOPs, and collaborative research infrastructure for ALS genetics across the consortium.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or Integration
Description

SURFsara computing platform in the Netherlands handles secure storage of Project MinE data. The system adheres to strict security protocols ensuring data protection and compliance with privacy regulations including GDPR. High-throughput computation continues to utilize SURF infrastructure.

Strategic tierCoreTypeTechnology or Integration
Description

DNA Nexus platform on AWS chosen for processing Data Freeze 4 (DF4). The ISO27001-certified environment has all required legal and data-governance documents in place (DPIA, DPA, DMP, MSA, SCC). Platform enables joint access, scalable computational workflows, and integration of multimodal data including MRI, proteomics, and NfL biomarkers.

3Longitude Prize on ALS
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Project MinE is a key data contributor to the Longitude Prize on ALS, a £7.5 million global challenge. Project MinE harmonized previously scattered whole genome sequencing datasets into a single coherent dataset enabling 20 Discovery Award teams to pursue AI-driven ALS treatments. Winning teams gained access to genomic sequences of 9,000 patients plus epigenomics, transcriptomics, and proteomics data.

projectmine.com
4Rostock University Medical Center
Strategic tierCoreTypeStrategic or Co-development Partner
Description

New consortium member added June 2026. Main ALS centre in Mecklenburg, Germany offering primary diagnostics, genetic testing, patient care for all stages of ALS. Expertise in deep phenotyping including cognitive/behavioral endophenotypes, molecular imaging, biomarker research, and patient-derived cell models. Prof. Dr. Andreas Hermann leads the Translational Neurodegeneration Section.

projectmine.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

New consortium member added June 2026. Located in Palermo, Italy, this is one of Sicily's largest public rehabilitation hospitals. ALS Center provides comprehensive diagnostic, management, and rehabilitation services for ALS patients. Dr. Rossella Spataro leads the Rare Diseases Center and Prof. Francesca Luisa Conforti from University of Calabria contributes genetic expertise.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Population-scale human genetics company operating the world's largest WGS dataset for disease gene discovery — comparable technology platform and genomic data scale, but in a commercial and population-wide context.

TypeDirect peer
Description

Non-profit consortium funding collaborative ALS research, including genomic and transcriptomic resources and shared core facilities — overlapping mandate and operating model with Project MinE.

TypeOthers
Description

Large-scale population biobank with WGS and deep phenotyping available to approved researchers — comparable controlled-access, GDPR-style data governance model used for genetic discoveries across diseases including ALS.

TypeDirect peer
Description

Non-profit biotech focused on ALS drug discovery, maintaining its own large biobank and genomic resources of ALS patient samples — directly comparable disease-specific research mandate.

TypeBroad incumbent
Description

Umbrella organization coordinating national ALS/MND associations and the International Symposium on ALS/MND — directly comparable global convening and research-advocacy mission.

TypeBroad incumbent
Description

US federal ALS registry and biorepository linking patient data with biospecimens for research — comparable global-scale ALS patient cohort infrastructure, though with broader epidemiologic rather than WGS focus.

TypeDirect peer
Description

Large-scale multi-omic ALS research program generating WGS, RNA-seq, and iPSC-derived motor neuron data from ALS patients — directly comparable to Project MinE as the other flagship ALS genomics data resource.

TypeDirect peer
Description

NYGC's ALS Consortium performs large-scale WGS and multi-omic profiling of ALS patients using centralized sequencing infrastructure — comparable approach and population-scale ALS genomics focus.

9Genomics England
TypeBroad incumbent
Description

Government-backed initiative sequencing genomes at population scale for clinical and research use — comparable large-cohort WGS infrastructure and controlled-access data model in a regulated environment.

TypeBroad incumbent
Description

Large US non-profit that funds ALS research and patient services globally, including genomics initiatives like the TREAT ALS network — comparable funder and ecosystem-builder role to Dutch ALS Foundation for Project MinE.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Project Mine

Genomic Research Consortiumprojectmine.com

Project Mine firmographics

Firmographics
Name
Project Mine
Legal name
Project MinE
Website
https://projectmine.com
Company type
Private
Founded year
2013
Operating status
Operating
Ownership category
akta.pro rank

Project Mine industry classification

Industry
Product category
Genomic Research Consortium
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Other Computer Related Services (541519)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAJAIAK
Public Health Genomics & Sequencing (WGS/Metagenomics) Networks
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks
SECONDARYHLAJABAC
Laboratory-Based Surveillance & Genomic Epidemiology (WGS/NGS)
Healthcare & Life Sciences/Public Health, Government & Regulators/Disease Surveillance, Epidemiology & Outbreak Response

Keywords

  • ALS genetics research
  • Whole genome sequencing
  • Genomic data consortium
  • Rare disease genomics
  • Neurodegenerative disease research

Where Project Mine is headquartered

Location

Headquarters

HQ city
Utrecht
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

Project Mine business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Infrastructure, Personnel, Operations

Revenue model

  1. Research Funding and Grants: Project MinE is a non-profit research consortium funded by the Dutch ALS Foundation and other research grants. All data used in publications was made accessible through funding by the Dutch ALS Foundation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Project Mine product offering

Product offering

Core offering

Project MinE is an international research consortium of 30+ centers across 21 countries that collects, processes, and shares whole genome sequencing (WGS) data from ALS patients and healthy controls. It operates a controlled-access Data Access Program, a public Variant Browser, and downloadable GWAS summary statistics, supported by six specialized working groups covering phenotyping, association testing, epigenetics, structural variation, non-coding variation, and trans-ancestral genetics.

Product overview

Project MinE is the largest ALS genetics research consortium in the world, comprising over 30 research centers from 21 countries. The consortium operates as a unified research platform centered on a whole genome sequencing (WGS) database of ALS patients and healthy controls. The core offerings include the Project MinE Data Browser for variant visualization, downloadable GWAS summary statistics from landmark publications, a controlled WGS data access program for qualified researchers, and specialized working group services providing standardized methodologies for phenotyping, association testing, epigenetics, structural variation, non-coding variation, and trans-ancestral genetics research. The consortium has produced major publications in Nature Genetics (2016, 2021) and contributed harmonized data to the Longitude Prize on ALS initiative.

Differentiator

Problem solved

Functional benefit

Products and services

  • Project MinE Data Browser Web-based variant browser enabling visualization and exploration of whole genomes from European-ancestry populations, ALS GWAS summary statistics, and burden test results across over 15,000 genes; aimed at qualified researchers studying ALS genetics.
  • ALS GWAS Summary Statistics Downloadable GWAS summary statistics from cross-ancestry and European-ancestry meta-analyses, rare-variant burden analysis results, and eQTL SMR summary statistics for eQTLGen and MetaBrain datasets; intended for use by qualified ALS genetics researchers.
  • WGS Data Access Program Controlled data access service that allows qualified researchers to request individual-level genotype or whole genome sequencing data via a formal application process, data access agreements, and secure data transfer mechanisms; available to both academic and commercial researchers, with commercial access limited.
  • Working Group Research Services Six specialized working groups (Phenotyping, Analysis and Association Testing, Epigenetics, Genomic Structural Variation, Non-coding Genomic Variation, and Trans-Ancestral Genetics) providing standardized methodologies, SOPs, and collaborative research infrastructure for ALS genetics across the consortium.

Quantifiable outcome

  • 25% of ALS patients now have identifiable genetic cause (up from 20%)
  • +2 more outcomes

Companies that use Project Mine

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Project Mine technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Project Mine partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and major.

  • SURFsaracoreTechnology or IntegrationSURFsara computing platform in the Netherlands handles secure storage of Project MinE data. The system adheres to strict security protocols ensuring data protection and compliance with privacy regulations including GDPR. High-throughput computation continues to utilize SURF infrastructure.
  • DNA Nexus (AWS)coreTechnology or IntegrationDNA Nexus platform on AWS chosen for processing Data Freeze 4 (DF4). The ISO27001-certified environment has all required legal and data-governance documents in place (DPIA, DPA, DMP, MSA, SCC). Platform enables joint access, scalable computational workflows, and integration of multimodal data including MRI, proteomics, and NfL biomarkers.
  • Longitude Prize on ALSmajorStrategic or Co-development PartnerProject MinE is a key data contributor to the Longitude Prize on ALS, a £7.5 million global challenge. Project MinE harmonized previously scattered whole genome sequencing datasets into a single coherent dataset enabling 20 Discovery Award teams to pursue AI-driven ALS treatments. Winning teams gained access to genomic sequences of 9,000 patients plus epigenomics, transcriptomics, and proteomics data.
  • Rostock University Medical CentercoreStrategic or Co-development PartnerNew consortium member added June 2026. Main ALS centre in Mecklenburg, Germany offering primary diagnostics, genetic testing, patient care for all stages of ALS. Expertise in deep phenotyping including cognitive/behavioral endophenotypes, molecular imaging, biomarker research, and patient-derived cell models. Prof. Dr. Andreas Hermann leads the Translational Neurodegeneration Section.
  • Villa delle Ginestre HospitalcoreStrategic or Co-development PartnerNew consortium member added June 2026. Located in Palermo, Italy, this is one of Sicily's largest public rehabilitation hospitals. ALS Center provides comprehensive diagnostic, management, and rehabilitation services for ALS patients. Dr. Rossella Spataro leads the Rare Diseases Center and Prof. Francesca Luisa Conforti from University of Calabria contributes genetic expertise.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Project Mine competitors and assessment

Company assessment

Broad incumbents

  • deCODE genetics (Amgen): Population-scale human genetics company operating the world's largest WGS dataset for disease gene discovery — comparable technology platform and genomic data scale, but in a commercial and population-wide context.
  • International Alliance of ALS/MND Associations: Umbrella organization coordinating national ALS/MND associations and the International Symposium on ALS/MND — directly comparable global convening and research-advocacy mission.
  • NIH National ALS Registry / Biorepository: US federal ALS registry and biorepository linking patient data with biospecimens for research — comparable global-scale ALS patient cohort infrastructure, though with broader epidemiologic rather than WGS focus.
  • Genomics England: Government-backed initiative sequencing genomes at population scale for clinical and research use — comparable large-cohort WGS infrastructure and controlled-access data model in a regulated environment.
  • The ALS Association: Large US non-profit that funds ALS research and patient services globally, including genomics initiatives like the TREAT ALS network — comparable funder and ecosystem-builder role to Dutch ALS Foundation for Project MinE.

Direct peers

  • Target ALS: Non-profit consortium funding collaborative ALS research, including genomic and transcriptomic resources and shared core facilities — overlapping mandate and operating model with Project MinE.
  • ALS Therapy Development Institute (ALS TDI): Non-profit biotech focused on ALS drug discovery, maintaining its own large biobank and genomic resources of ALS patient samples — directly comparable disease-specific research mandate.
  • Answer ALS: Large-scale multi-omic ALS research program generating WGS, RNA-seq, and iPSC-derived motor neuron data from ALS patients — directly comparable to Project MinE as the other flagship ALS genomics data resource.
  • New York Genome Center (NYGC) ALS Consortium: NYGC's ALS Consortium performs large-scale WGS and multi-omic profiling of ALS patients using centralized sequencing infrastructure — comparable approach and population-scale ALS genomics focus.

Others

  • UK Biobank: Large-scale population biobank with WGS and deep phenotyping available to approved researchers — comparable controlled-access, GDPR-style data governance model used for genetic discoveries across diseases including ALS.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Project Mine social profiles

Digital presence

Project Mine compliance and trust

Trust signal

Compliance1 record

Project Mine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Project Mine leadership team

Management profile

Number of profiles

Profiles11 records

Project Mine funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Project Mine M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Project Mine

What does Project Mine do?

Project MinE is an international research consortium of 30+ centers across 21 countries that collects, processes, and shares whole genome sequencing (WGS) data from ALS patients and healthy controls. It operates a controlled-access Data Access Program, a public Variant Browser, and downloadable GWAS summary statistics, supported by six specialized working groups covering phenotyping, association testing, epigenetics, structural variation, non-coding variation, and trans-ancestral genetics.

Is Project Mine a public or private company?

Project Mine is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Project Mine founded?

Project Mine was founded in 2013.

Where is Project Mine based?

Project Mine is headquartered in Utrecht, Netherlands, in the Europe region.

How does Project Mine make money?

One revenue line is on record: research Funding and Grants.

Who are Project Mine's main competitors?

Broad incumbents on record are deCODE genetics (Amgen), International Alliance of ALS/MND Associations, NIH National ALS Registry / Biorepository, Genomics England and The ALS Association. Direct peers are Target ALS, ALS Therapy Development Institute (ALS TDI), Answer ALS and New York Genome Center (NYGC) ALS Consortium. UK Biobank is listed as an others.

Does Project Mine have an API?

No public API is recorded for Project Mine.

What industry is Project Mine in?

Project Mine's product category is Genomic Research Consortium. Its primary akta.pro industry code is HLAJAIAK, Public Health Genomics & Sequencing (WGS/Metagenomics) Networks, with a secondary code of HLAJABAC, Laboratory-Based Surveillance & Genomic Epidemiology (WGS/NGS). Its NAICS code is 541715 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals